Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular mitochondrial network and energy metabolism represent a complex, integrated system responsible for the majority of cellular adenosine triphosphate (ATP) production through oxidative phosphorylation (Spinelli & Haigis, 2018, Nature Cell Biology). This network is highly dynamic, undergoing continuous cycles of fusion and fission to maintain organelle quality and respond to metabolic demands (Friedman & Nunnari, 2014, Nature). Beyond energy production, this system plays critical roles in calcium homeostasis, reactive oxygen species (ROS) signaling, and the initiation of programmed cell death (apoptosis) (Vafai & Mootha, 2012, Nature). Dysregulation of mitochondrial dynamics or metabolic pathways is a hallmark of numerous pathologies, including neurodegenerative disorders like Parkinson's disease, metabolic conditions such as type 2 diabetes, and various forms of cancer (Wallace, 2005, Genetics). While not a single molecular target, components of this network—such as the electron transport chain complexes and fusion/fission proteins—are increasingly explored as therapeutic nodes (Nunnari & Suomalainen, 2012, Cell). Pharmacological intervention often aims to restore bioenergetic efficiency or mitigate oxidative damage, though such approaches face significant challenges regarding tissue specificity and potential systemic toxicity (Murphy & Hartley, 2018, Nature Reviews Drug Discovery).
Drugs interacting with this system typically modulate the electron transport chain, stabilize mitochondrial membranes, or influence the balance of mitochondrial fission and fusion to restore metabolic homeostasis (Murphy & Hartley, 2018, Nature Reviews Drug Discovery).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular mitochondrial network and energy metabolism.